Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC20H20Cl2N8O3 |
InChIKeyQXCXMVYVUHVFLP-UHFFFAOYSA-N |
CAS Registry2253744-56-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | GB | 18 Apr 2024 |